[Epidemiological profile of allergic respiratory disease in Mexican children]

Sandra Nora González-Díaz1, Alejandra Macías-Weinmann1, Cindy Elizabeth De Lira-Quezada1

  • 1Regional Center of Allergy and Clinical Immunology, University Hospital Dr. José Eleuterio González, Monterrey, Mexico.

Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)
|September 19, 2024
PubMed

Insights

This study found that allergic diseases, specifically wheezing, affected over 30% of children and adolescents in Monterrey, Mexico. These findings highlight the need for targeted healthcare strategies for pediatric allergic conditions.

Area of Science:

  • Pediatric Allergy and Immunology
  • Epidemiology of Allergic Diseases
  • Public Health in Mexico

Background:

  • Allergic diseases represent a significant global health burden in pediatric populations.
  • Understanding local prevalence is crucial for effective public health interventions.
  • Monterrey, Mexico, lacks comprehensive data on common childhood allergies.

Purpose of the Study:

  • To determine the prevalence and severity of common allergic diseases in children and adolescents.
  • To establish baseline data for allergic conditions in the Monterrey metropolitan area.
  • To inform the development of targeted healthcare strategies.

Main Methods:

  • A cross-sectional, multi-center survey was conducted.
  • Data collected from parents of 6-7-year-old children and 13-14-year-old adolescents.
  • Surveys administered in the Monterrey metropolitan area between January 2018 and December 2019.

Main Results:

  • 3,044 questionnaires were analyzed.
  • Wheezing prevalence was 30.2% in 6-7-year-olds (higher in males).
  • Wheezing prevalence was 26.4% in adolescents (slight female predominance).

Conclusions:

  • The study provides essential prevalence data for allergic diseases in a key Mexican population.
  • This information is vital for creating effective healthcare strategies.
  • Addressing pediatric allergic diseases in Monterrey can improve patient outcomes.
Abstract

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
364
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Allergic Reactions02:06

Allergic Reactions

Overview
27.3K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
360
Physical Assessment of the Respiratory Tract I: Health History01:28

Physical Assessment of the Respiratory Tract I: Health History

Physical assessment of the respiratory tract is critical to patient care. It allows healthcare professionals to identify and manage various respiratory conditions. The process involves a combination of subjective and objective data collection.
Subjective Data
Subjective data provides vital information about the patient's health history and symptoms. This data is typically collected through interviews in which patients describe their experiences, symptoms, and concerns.
Health history and...
162